Over the years, we’ve been a leader in developing and manufacturing some of the world’s most sophisticated, life-saving therapies. As a top global CDMO, we are dedicated to you and your long-term success, and bring you the power and expertise of a large pharmaceutical manufacturer to help you scale you need it.
By using the latest technologies and harnessing the scientific excellence of our world-class experts, we’re on a mission to help deliver the quality and flexibility you need to lead your project to success.
Explore our expert suite of development and optimization services in our brochure
Read about Pfizer's harmonized approach to process development science
Read about Pfizer's approach to manufacturing excellence likened by their rowing story
With our global pharmaceutical manufacturing network and our scientific expertise and experience, we will find the best path for your product. We will work with you along the journey to help you scale your product to help you reach your product’s full potential from clinical to commercial with open dialogue
From early clinical phases through to commercial launch and lifecycle management, we are dedicated to the long-term success of your product. We’re able to scale with you every step of the journey by offering an expert suite of development and optimization services including:
Our proactive approach to problem solving your drug formulation and development issues, along with our expertise, helps us work to overcome challenges with creativity and compelling science.
The scientific development expertise within Pfizer has enabled the team to successfully develop breakthroughs that change patients’ lives
We leverage our scale-up and technology transfer experience to take your project further
We have a roster of analytical chemists, organic chemists and engineers who are adept at developing and trouble-shooting analytical methods and processes and have the expertise to help scale up your API process.
Therapeutic protein and antibody production including vaccine drug substance, monoclonal antibodies (mAbs), antibody drug conjugates (ADCs) and mAb biosimilars.
From pellets, tablets and capsules to innovative release profiles, we have the global expertise to help meet your needs across a wide range of platforms and technologies.
From liquid and lyophilization to pre-filled syringes, vials and cartridges - helping you unlock the potential of your sterile injectable.
Tom Wilson leads Pfizer CentreOne's global contract manufacturing commercial business. Tom was formerly Vice President of Contract Manufacturing Operations where he was the liaison between the Pfizer Global Supply (PGS) and Pfizer CentreOne organizations. He also led the Pfizer Optionality Program for PGS, as well as the Integration Team for Hospira Device Operations, oversaw management of Pfizer’s Alliance External Suppliers worldwide, and provided counsel on Pfizer’s global manufacturing strategy. He joined Pfizer in 2010 with the acquisition of Wyeth, where he was Vice President of Product Operations.
Tom is a former United States Air Force Captain, serving as a Command and Control Officer. He holds a BSc in Physics from Saint Joseph's University and an MSc in Administration and Management from Saint Michael's College.
Nicole Strauss is Pfizer CentreOne’s Pipeline Development and Innovation Lead. She manages a team dedicated to identifying growth opportunities and new technologies across the business and oversees Pfizer CentreOne’s technical, regulatory and development services.
Nicole brings a wide range of expertise to her role including contract manufacturing operations, procurement, business development, and sourcing strategies. She also has over 18 years of experience working with Pfizer’s third-party manufacturers.
Nicole holds a BSc Degree in Chemical Engineering from the Georgia Institute of Technology and an MBA from the University of Delaware.
Jim Donovan leads Pfizer CentreOne operations across the Pfizer Global Supply network. His team ensures the manufacture of customer products in a safe, timely, cost-effective, and compliant manner.
Jim has over 25 years of experience in operations and finance with most recent roles as Site Leader at multiple Pfizer manufacturing sites focused on the production of emergency-use auto-injectors, class I medical devices, and various OTC consumer products.
Jim hold a BS in Chemical Engineering from Manhattan college and an MBA in Finance from Fordham University.